Dhavalkumar Patel

Dhavalkumar Patel

Company: UCB

Job title: Executive Vice President & Chief Scientific Officer


Therapeutic Potential in Targeting the FcRn Receptor: Clinical Overview and Future Opportunities 3:20 pm

FcRn is a promising therapeutic target because it has a vital role in prolonging the half-life of IgG blood levels FcRn inhibitors are in clinical development for numerous autoantibodymediated diseases FcRn effects may vary with physiological location and additional effects are still being discoveredRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.